A potent nootropic peptide derived from BDNF that enhances memory, learning, and cognitive function. Crosses the blood-brain barrier effectively.
Dihexa (N-hexanoic-tyrosine-isoleucine-(6) aminohexanoic amide) is a synthetic neuropeptide derived from angiotensin IV. It was developed by researchers at Washington State University as a potential treatment for neurodegenerative conditions and chemically modified to enhance potency and blood-brain barrier penetration.
Dihexa binds with high affinity to hepatocyte growth factor (HGF) and promotes c-Met signaling and HGF-dependent cellular activity. Activation of c-Met can stimulate neurogenesis and protect against tissue insults in many cell types including neurons. These activities are linked to improved cognitive function and increased dendritic arborization, spinogenesis, and synaptogenesis.
Not established. In rats, dihexa has been tested orally at 2 mg/kg, i.c.v. at up to 1 nmol, i.v. at up to 10 mg/kg, and i.p. at up to 20 mg/kg.
No long-term safety studies in animals or humans exist. There are theoretical concerns of c-Met activation leading to tumorigenesis and cancer progression.
Pinealon
A short peptide bioregulator that supports pineal gland function and melatonin production. Part of the Khavinson peptide family.
2 mgN-Acetyl Semax Amidate
N-Acetyl Semax Amidate is a modified version of the Semax peptide, engineered for improved stability and enhanced potency. It is currently under investigation for a variety of nootropic and neuroprotective effects, including memory improvement and mood regulation.
300-1000 mcgN-Acetyl Selank Amidate
N-Acetyl Selank Amidate is a modified version of the nootropic peptide Selank, engineered for enhanced stability and improved blood-brain barrier permeability. It exhibits anxiolytic and cognitive-enhancing properties similar to its parent compound.
600-2700 mcgP21
A synthetic CNTF-derived peptide that promotes neurogenesis and cognitive function. Studied for neurodegenerative disease and brain health.
5-10 mg